Search Results
Search for other papers by Philippe Jean-Luc Gradidge in
Google Scholar
PubMed
Search for other papers by Nicole G Jaff in
Google Scholar
PubMed
Global Health Research Institute, School of Human Development and Health, University of Southampton, Southampton, UK
Search for other papers by Shane A Norris in
Google Scholar
PubMed
Search for other papers by Marketa Toman in
Google Scholar
PubMed
Search for other papers by Nigel J Crowther in
Google Scholar
PubMed
Africa. BT20 plus is supported by the Wellcome Trust and Gates Foundation. S A N is supported by the DSI-NRF Centre of Excellence in Human Development at the University of the Witwatersrand, Johannesburg, South Africa. Author contribution statement
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Xiaohui Qi in
Google Scholar
PubMed
Search for other papers by Ping He in
Google Scholar
PubMed
Search for other papers by Huayan Yao in
Google Scholar
PubMed
Search for other papers by Huanhuan Sun in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Jiying Qi in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Min Cao in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Bin Cui in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Guang Ning in
Google Scholar
PubMed
shown that insulin and insulin-like growth factor (IGF) are involved in the development and progression of malignancies ( 9 , 10 ). Insulin has been reported to be associated with an increased risk of several cancer sites, such as the liver, pancreas
Weihai Institute for Bionics, Jilin University, Weihai, China
Search for other papers by Xiaohui Weng in
Google Scholar
PubMed
Search for other papers by Gehong Li in
Google Scholar
PubMed
Search for other papers by Ziwei Liu in
Google Scholar
PubMed
Search for other papers by Rui Liu in
Google Scholar
PubMed
Search for other papers by Zhaoyang Liu in
Google Scholar
PubMed
Search for other papers by Songyang Wang in
Google Scholar
PubMed
Search for other papers by Shishun Zhao in
Google Scholar
PubMed
Search for other papers by Xiaotong Ma in
Google Scholar
PubMed
College of Biological and Agricultural Engineering, Jilin University, Changchun, China
Key Laboratory of Bionic Engineering, Ministry of Education, Jilin University, Changchun, China
Search for other papers by Zhiyong Chang in
Google Scholar
PubMed
conflict of interest that could be perceived as prejudicing the impartiality of this review. Funding This work was supported by the National Natural Science Foundation of China (51875245), the Science-Technology Development Plan Project of Jilin
Search for other papers by Nobuo Matsuura in
Google Scholar
PubMed
Search for other papers by Tadashi Kaname in
Google Scholar
PubMed
Search for other papers by Norio Niikawa in
Google Scholar
PubMed
Search for other papers by Yoshihide Ooyama in
Google Scholar
PubMed
Search for other papers by Osamu Shinohara in
Google Scholar
PubMed
Search for other papers by Yukifumi Yokota in
Google Scholar
PubMed
Search for other papers by Shigeyuki Ohtsu in
Google Scholar
PubMed
Search for other papers by Noriyuki Takubo in
Google Scholar
PubMed
Search for other papers by Kazuteru Kitsuda in
Google Scholar
PubMed
Search for other papers by Keiko Shibayama in
Google Scholar
PubMed
Search for other papers by Fumio Takada in
Google Scholar
PubMed
Search for other papers by Akemi Koike in
Google Scholar
PubMed
Search for other papers by Hitomi Sano in
Google Scholar
PubMed
Search for other papers by Yoshiya Ito in
Google Scholar
PubMed
Search for other papers by Kenji Ishikura in
Google Scholar
PubMed
JC Rothenbuhler A Lingart A . Progressive development of PTH resistance in patients with inactivating mutations on the maternal allele of GNAS . Journal of Clinical Endocrinology and Metabolism 2017 102 1844 – 1850 . ( https://doi.org/10
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Weiwei He in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Caoxin Huang in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Xiulin Shi in
Google Scholar
PubMed
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Menghua Wu in
Google Scholar
PubMed
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Han Li in
Google Scholar
PubMed
Xiamen Diabetes Institute, The First Affiliated Hospital of Xiamen University, Xiamen, China
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Qiuhong Liu in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Xiaofang Zhang in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Search for other papers by Yan Zhao in
Google Scholar
PubMed
Fujian Provincial Key Laboratory of Translational Medicine for Diabetes, Xiamen, China
Department of Endocrinology and Diabetes, The First Affiliated Hospital of Xiamen University, Xiamen, China
Xiamen Clinical Medical Center for Endocrine and Metabolic Diseases, Xiamen Diabetes Prevention and Treatment Center, Xiamen, China
Search for other papers by Xuejun Li in
Google Scholar
PubMed
imbalance between ECM synthesis and degradation can lead to the development of liver fibrosis ( 16 , 17 , 18 ). Activation of the HSCs is currently regarded as a central event in liver fibrosis ( 19 , 20 ). Studies over the last two decades have shown
Search for other papers by Qian Deng in
Google Scholar
PubMed
Search for other papers by Yue Zhu in
Google Scholar
PubMed
Search for other papers by Mengmeng Zhang in
Google Scholar
PubMed
Search for other papers by Aihua Fei in
Google Scholar
PubMed
Search for other papers by Jiaqi Liang in
Google Scholar
PubMed
Search for other papers by Jinjin Zheng in
Google Scholar
PubMed
Search for other papers by Qingping Zhang in
Google Scholar
PubMed
Search for other papers by Tong Cheng in
Google Scholar
PubMed
Search for other papers by Xia Ge in
Google Scholar
PubMed
observations demonstrated that the activation of the Nrf2/GPX4 axis could protect β cells from ferroptosis. Collectively, the occurrence and development of diabetes may be tightly associated with ferroptosis. Overview of ferroptosis Ferroptosis is an
Search for other papers by Ying Pei in
Google Scholar
PubMed
Search for other papers by Rui Wang in
Google Scholar
PubMed
Search for other papers by Wanyu Chen in
Google Scholar
PubMed
Search for other papers by Shulin Yi in
Google Scholar
PubMed
Search for other papers by Chen Huang in
Google Scholar
PubMed
Search for other papers by Shaochan Liang in
Google Scholar
PubMed
Search for other papers by Hongying Cao in
Google Scholar
PubMed
Search for other papers by Yifei Xu in
Google Scholar
PubMed
Search for other papers by Bo Tan in
Google Scholar
PubMed
intestinal motility ( 13 ). The gut microbiota plays a pivotal role in ENS development and physiological function ( 14 ). Germ-free mice exhibited abnormalities in ENS morphology and activity ( 15 ). The interaction between gut microbiota and ENS has been
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Hairong Hao in
Google Scholar
PubMed
Search for other papers by Linghui Kong in
Google Scholar
PubMed
Search for other papers by Jie Zhang in
Google Scholar
PubMed
Search for other papers by Feng Bai in
Google Scholar
PubMed
Search for other papers by Fei Guo in
Google Scholar
PubMed
Search for other papers by Pan Wei in
Google Scholar
PubMed
Search for other papers by Rui Chen in
Google Scholar
PubMed
Search for other papers by Wen Hu in
Google Scholar
PubMed
development of metabolic diseases, but the causal relationship and mechanism between BCAAs and cardiometabolic diseases are still not fully understood. In this study, the elevation of BCAAs occurred earlier than other metabolic disorders. To better reveal the
Search for other papers by Svjatoslavs Kistkins in
Google Scholar
PubMed
Search for other papers by Othmar Moser in
Google Scholar
PubMed
Search for other papers by Vitālijs Ankudovičs in
Google Scholar
PubMed
Search for other papers by Dmitrijs Blizņuks in
Google Scholar
PubMed
Search for other papers by Timurs Mihailovs in
Google Scholar
PubMed
Search for other papers by Sergejs Lobanovs in
Google Scholar
PubMed
Search for other papers by Harald Sourij in
Google Scholar
PubMed
Search for other papers by Andreas F H Pfeiffer in
Google Scholar
PubMed
Faculty of Medicine, University of Latvia, Riga, Latvia
Search for other papers by Valdis Pīrāgs in
Google Scholar
PubMed
, retatrutide was demonstrated in obese people to reduce body weight by up to 24.2% over 48 weeks ( 12 ). In addition, dual agonists, combining GLP1 and glucagon receptor activation are currently under development, of which survodutide (BI 456906) was shown to
Search for other papers by Annalisa Blasetti in
Google Scholar
PubMed
Search for other papers by Valeria Castorani in
Google Scholar
PubMed
Search for other papers by Nella Polidori in
Google Scholar
PubMed
Search for other papers by Ilaria Mascioli in
Google Scholar
PubMed
Search for other papers by Francesco Chiarelli in
Google Scholar
PubMed
Search for other papers by Cosimo Giannini in
Google Scholar
PubMed
anthropometric development in children with T1D ( 1 , 2 ). The Mauriac syndrome, characterized by growth failure and hepatomegaly, constitutes the most critical growth-related condition characterized by long-term and poorly controlled T1D in relation to chronic